Abstract:Type 1 diabetes (T1D) is an autoimmune disease resulting from T cell-mediated β cell destruction in the pancreas of genetically susceptible individuals. Extensive familial and population genetic studies uncovered the strong linkage and association between HLA gene variants and T1D. Non-HLA genes have also been associated with T1D, such as INS, CTLA4, and PTPN22. T1D is considered as one of the most heritable common diseases. However, evidence that monozygotic twins have incomplete concordance of disease susceptibility provides convincing proof that environmental factors also play important roles in the pathogenesis of the disease. Environmental factors can induce the alterations of gene expression via epigenetic mechanisms. Epigenetic modifications refer to the alterations in gene expression without changes of the DNA sequence, but instead occur as a result of DNA methylation, histone modifications, and miRNA regulation. Aberrant epigenetic modifications will cause the dysregulation of gene expression, thus leading to a variety of human diseases. There are significant differences in DNA methylation, histone modifications, and miRNA profiling found in T1D patients compared with healthy individuals. Epigenetic modifications contribute to the pathogenesis of T1D mainly by regulating the expression of susceptible genes in T1D. These susceptible genes are involved in antigen presentation (such as HLA), immune tolerance (such as FOXP3 and CTLA4), autoreactive T cell response (such as GAD65), and β cell functions (such as INS). A better understanding of epigenetic mechanisms for regulating susceptible genes of T1D will help identify candidates that target epigenetic pathways to control and/or prevent T1D. Knowledge of epigenetic changes in T1D also provides us with potential biomarkers for diagnosis, prognostication, personalized treatment, and prevention of the disease.

The new development in genetic studies of type 1 diabetes mellitus

Fine Mapping of Type 1 Diabetes Susceptibility Loci and Evidence for Colocalization of Causal Variants with Lymphoid Gene Enhancers.

Implication of epigenetic factors in the pathogenesis of type 1 diabetes

Genetic advances of type 2 diabetes in Chinese populations.

Beyond Genetics: What Causes Type 1 Diabetes

Emerging roles of rare and low-frequency genetic variants in type 1 diabetes mellitus

Genome-Wide Scan for Linkage to Type 1 Diabetes in 2,496 Multiplex Families from the Type 1 Diabetes Genetics Consortium

Study of Functional L1 Retrotransposon in Human Type 2 Diabetes Susceptibility Loci

1463-P: Genetic Heterogeneity and Clinical Subtypes of Type 1 Diabetes

Feature Ranking of Type 1 Diabetes Susceptibility Genes Improves Prediction of Type 1 Diabetes

Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes

The missing heritability in type 1 diabetes

Tests for Genetic Interactions in Type 1 Diabetes

The new perspectives on genetic studies of type 2 diabetes and thyroid diseases.

A multi-ancestry genome-wide association study in type 1 diabetes

Genetics of type 2 diabetes: insights into the pathogenesis and its clinical application.

Tests for genetic interactions in type 1 diabetes: linkage and stratification analyses of 4,422 affected sib-pairs.

Genetic and Epigenetic Aspects of Type 1 Diabetes Mellitus: Modern View on the Problem

Susceptible Genes of Type 2 Diabetes and Their Disease Predictive Power in Chinese Population

A genome-wide functional genomics approach uncovers genetic determinants of immune phenotypes in type 1 diabetes

The Role of Epigenetics in Type 1 Diabetes